Tele: 561.316.3330
Breaking Medical Device News

Monday, September 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeEXECUTIVESDr. Deborah A. Jeffries New Tryten Global Director of Healthcare

Dr. Deborah A. Jeffries New Tryten Global Director of Healthcare

Dr. Deborah A. Jeffries is Tryten new Global Director of Healthcare. Dr. Deborah A. Jeffries (Dr. Deb) brings 25 years of expertise in medicine, education, telehealth, video conferencing, virtual training, patient care, and healthcare industry trends.

Dr. Deb did undergraduate and post-graduate work in physics at UCLA. She received her ND from NCNM. She taught pathology at NCC, as well as pathophysiology and hematology at Merrimac College.

Dr. Deb will be helping Tryten to launch multi-purpose (video-capable) cart/vehicles for telemedicine encounters, video remote interpreting, patient observation, and electronic health record workstations.

“It is so exciting to join the team at Tryten. Today the healthcare system is challenged like never before. Not only are we experiencing a major paradigm shift to healthcare that is focused on workflow efficiencies, practitioner availability, patient-centered care, digital health, and cost containment, but now we are faced with a rapidly evolving pandemic and how to respond to COVID-19 and the multiple complexities it brings. We need to immediately focus on how to help.”

Tony Janzen, founder, and CEO of Tryten states, “We are excited that Dr. Deb has joined our growing team. Dr. Deb brings a level of professionalism and knowledge that makes her so valuable to the growth and development of Tryten.”

Dr. Deb will be focused on healthcare solutions and supporting Tryten’s marketing and sales efforts.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

By using this website you agree to accept Medical Device News Magazine Privacy Policy